The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

TIDES: Oligonucleotide and Peptide Therapeutics from Research through Commercialization

CSS

Agenda CSS

Access the hottest fields in therapeutics by attending TIDES - the only event with full coverage of discovery, development and manufacturing

May 12-15, 2014
Rhode Island Convention Center
Providence, RI

Alt Language

Alternative Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese

Agenda Summary

Agenda Summary

Agenda-at-a-Glance

 

Workshop #1:
Impurities in Oligonucleotides: Sources, Analysis and Control

Workshop #2:
Peptide Aggregation in Drug Substance and Drug Product

Workshop #3:
In vivo Delivery of Therapeutic Oligonucleotides: Challenges, Considerations and Solutions

Workshop #4:
Nucleic Acids Technologies for Molecular Diagnostics

AM

Keynote Presentations

PM

Plenary Presentations: Updates on Progress of Leading Therapeutic Candidates

Featured FDA Presentation

 

Networking Wine and Cheese Reception in Poster and Exhibit Hall Sponsored by Lonza

 

Oligonucleotide and Peptide Manufacturing, Technology and Product Development

Oligonucleotide Therapeutics Discovery

Peptide Discovery and Development

AM

Manufacturing Advances, Process Improvements and Scale Up

Audience Interactive Panel Discussion: Novel Strategies for the Scale-up of Oligonucleotide and Peptides: Thinking Outside the Box

Using Conjugation Technology to Advance Therapeutic Oligonucleotides and Peptides

Strategy Discussion Forum: Assessing the Current State of Conjugation, Fusion, and Encapsulation Technologies

Medicinal Chemistry and Chemical Modifications to Improve Oligonucleotide Properties

Panel Discussion: Do We Need to Transform Viral Safety Testing?

Peptide Discovery and Hit Finding

Display Technologies and Discovery Platforms

 

Networking Luncheon in Poster and Exhibit Hall Sponsored by Nitto Denko Avecia Inc.

PM

Advances in Analytics and Control

Audience Interactive Panel Discussion: Challenges with Novel Technologies for the Analysis and Control of Oligonucleotides and Peptides

Emerging Technologies

Viral Contamination Risk-Mitigation Strategies

Discovery and Preclinical Strategies

Audience Interactive Panel Discussion: What Constitutes a Good Target for Oligonucleotide Modalities?

Computational Modeling and Design of Peptides

Optimization Strategies for Peptide-like Molecules

 

Networking Cocktail Reception in Poster and Exhibit Hall

 

Oligonucleotide and Peptide Manufacturing, Technology and Product Development

Oligonucleotide Therapeutics Discovery

Peptide Discovery and Development

AM

Process Validation: Design, Qualify, Verify

Strategy Discussion Forum: What's Changed in our Approach to Process Validation?

Formulation and Delivery Technologies: Enabling Peptide and Oligo Product Opportunities

Strategy Discussion Forum: Assessing the Current State of Conjugation, Fusion, and Encapsulation Technologies

PK/PD and Toxicity of Oligonucleotides

Preclinical and Clinical Oligonucleotides

Peptides in Preclinical and Clinical Development

 

Networking Luncheon in Poster and Exhibit Hall Sponsored by Nitto Denko Avecia Inc.

PM

Raw Materials and Supply Chain: Assessing and Mitigating Risk with Novel and Traditional Starting Materials

Strategy Discussion Forum: Where Does Your Building Block Come From?

Formulation and Delivery Technologies: Enabling Peptide and Oligo Product Opportunities

Strategy Discussion Forum: Challenges in CMC Development of Novel Delivery Systems: Functional Excipients, Novel Formulations and Regulatory Expectations

Preclinical and Clinical Oligonucleotides

Endosomal Escape, Peptide Targeting and Intracellular Delivery

Click on the track titles below to view the full agenda for each track. Check back soon and we will have an agenda-at-a-glance grid on this page.

Monday Workhops

Monday, May 12, 2014

  • Workshop #1: Impurities in Oligonucleotides: Sources, Analysis and Control
  • Workshop #2: Peptide Aggregation in Drug Substance and Drug Product
  • Workshop #3: In vivo Delivery of Therapeutic Oligonucleotides: Challenges, Considerations and Solutions
  • Workshop #4: Nucleic Acids Technologies for Molecular Diagnostics

Tuesday Keynotes & Plenary Sessions

Tuesday, May 13, 2014

Wednesday-Thursday Tracks

Wednesday, May 14, 2014 and Thursday, May 15, 2014

skyline